- Doravirine is available as a pill and sold under the brand name Pifeltro. It belongs to the class of anti-HIV drugs called non-nukes (NNRTIs). Doravirine is ...
- Fostemsavir is a drug that has completed phase III clinical trials. It is intended for use by people who have strains of HIV that are resistant to many classes ...
- HIV-positive people who doctors described as “heavily treatment-experienced” were enrolled in a study on fostemsavir called Brighte. Most participants had ...
- ViiV Healthcare has built at least one manufacturing facility to make fostemsavir. The factory should have some supplies of fostemsavir available toward the end ...
- The widespread availability of potent HIV treatment (ART) in Canada and other high-income countries has largely transformed HIV infection into a chronic ...
- CATIE NewsU.S. researchers studied the motor functions of 354 long-term survivors of HIV. 69% of participants had some degree of movement problems, such as muscle ...
- Presented here are the most recent available data on overdoses and deaths involving opioids and/or stimulants from January 2016 to December 2022 in Canada, where available.
- CATIE NewsSexual transmission of hepatitis C has been observed among men who have sex with men. A study of 429 men taking PrEP identified factors associated with ...
- CATIE NewsA U.S. study reviewed the medical records of 196 HIV-positive people treated for cancer. Chemotherapy and radiation treatment were linked to declines in CD4+ ...
- CATIE NewsSome health conditions in HIV-positive people increase the risk of fatty liver disease. Montreal researchers studied the effect of vitamin E in HIV-positive ...
- The pharmaceutical companies that make hepatitis C medications have programs to help people access and complete treatment.